Medicines / Emcure Pharmaceuticals / Instgra

InstgraDolutegravir

Instgra is marketed by Emcure Pharmaceuticals. 2 packs on NPPA's price list for July 2026, containing Dolutegravir.

Packs listed
2
Lowest MRP
₹3,421
Per unit
₹114.02 to ₹118.77
Price-controlled packs
2 of 2
Dosage forms
1

Packs and prices

  1. ₹3,421Instgra 50 mg Tablet 30Dolutegravir Tablet 50 mg · ₹114.02 per tablet · price-controlled, ceiling ₹115.49 per tablet
  2. ₹10,689Instgra 50 mg Tablet 90Dolutegravir Tablet 50 mg · ₹118.77 per tablet · price-controlled, ceiling ₹115.49 per tablet

The same composition from other brands

Packs with the identical filed composition, form and strength. A different brand is not automatically interchangeable: ask your doctor or pharmacist.

Dolutegravir Tablet 50 mg

  1. ₹103.10/tabletMyltega · 30 tabletViatris · MRP ₹3,093 · price-controlled, ceiling ₹115.49 per tablet
  2. ₹118.83/tabletXapavir · 30 tabletNatco Pharma · MRP ₹3,565 · price-controlled, ceiling ₹115.49 per tablet
  3. ₹143.42/tabletTwinaqt · 30 tabletEmcure Pharmaceuticals · MRP ₹4,303 · price-controlled, ceiling ₹115.49 per tablet

3 other brands of this composition on the price list; the 3 lowest per tablet are shown. All Dolutegravir packs

The company

Emcure Pharmaceuticals has 1,373 packs on the price list, and CDSCO has named it as the manufacturer of 4 failed batches since Mar 2019. Company record

Prices are the maximum retail prices each company filed with the National Pharmaceutical Pricing Authority (NPPA) for July 2026, read from NPPA's Pharma Sahi Daam service on 2 Oct 2026. A price in a shop can be lower; it may not lawfully be higher. Failed batches are those CDSCO and state laboratories declared not of standard quality. This is a record of prices and filings, not medical advice: do not change a medicine without your doctor or pharmacist. Source: NPPA and CDSCO, Government of India. About this record.

COUNTERFOIL / CONTACT

Contact us.

How can we help?

Stored privately by Counterfoil. Your email is used only to respond to your enquiry.